Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Basic Research
You have accessRestricted Access

Origin of Parietal Podocytes in Atubular Glomeruli Mapped by Lineage Tracing

Kevin Schulte, Katja Berger, Peter Boor, Peggy Jirak, Irwin H. Gelman, Kenton P. Arkill, Christopher R. Neal, Wilhelm Kriz, Jürgen Floege, Bart Smeets and Marcus J. Moeller
JASN January 2014, 25 (1) 129-141; DOI: https://doi.org/10.1681/ASN.2013040376
Kevin Schulte
*Department of Nephrology and Immunology, RWTH University of Aachen, Aachen, NRW, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katja Berger
*Department of Nephrology and Immunology, RWTH University of Aachen, Aachen, NRW, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Boor
*Department of Nephrology and Immunology, RWTH University of Aachen, Aachen, NRW, Germany;
†Institute of Pathology, RWTH University of Aachen, Aachen, NRW, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peggy Jirak
*Department of Nephrology and Immunology, RWTH University of Aachen, Aachen, NRW, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irwin H. Gelman
‡Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenton P. Arkill
§Department of Physiology, University of Bristol, Bristol, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher R. Neal
§Department of Physiology, University of Bristol, Bristol, United Kingdom; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wilhelm Kriz
‖Institute for Anatomy, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Ba-Wue, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jürgen Floege
*Department of Nephrology and Immunology, RWTH University of Aachen, Aachen, NRW, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bart Smeets
*Department of Nephrology and Immunology, RWTH University of Aachen, Aachen, NRW, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus J. Moeller
*Department of Nephrology and Immunology, RWTH University of Aachen, Aachen, NRW, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

Parietal podocytes are fully differentiated podocytes lining Bowman’s capsule where normally only parietal epithelial cells (PECs) are found. Parietal podocytes form throughout life and are regularly observed in human biopsies, particularly in atubular glomeruli of diseased kidneys; however, the origin of parietal podocytes is unresolved. To assess the capacity of PECs to transdifferentiate into parietal podocytes, we developed and characterized a novel method for creating atubular glomeruli by electrocoagulation of the renal cortex in mice. Electrocoagulation produced multiple atubular glomeruli containing PECs as well as parietal podocytes that projected from the vascular pole and lined Bowman’s capsule. Notably, induction of cell death was evident in some PECs. In contrast, Bowman’s capsules of control animals and normal glomeruli of electrocoagulated kidneys rarely contained podocytes. PECs and podocytes were traced by inducible and irreversible genetic tagging using triple transgenic mice (PEC- or Pod-rtTA/LC1/R26R). Examination of serial cryosections indicated that visceral podocytes migrated onto Bowman’s capsule via the vascular stalk; direct transdifferentiation from PECs to podocytes was not observed. Similar results were obtained in a unilateral ureter obstruction model and in human diseased kidney biopsies, in which overlap of PEC- or podocyte-specific antibody staining indicative of gradual differentiation did not occur. These results suggest that induction of atubular glomeruli leads to ablation of PECs and subsequent migration of visceral podocytes onto Bowman’s capsule, rather than transdifferentiation from PECs to parietal podocytes.

Multiple studies have reported the presence of podocytes on Bowman’s capsule in normal1 and diseased kidneys, close to the vascular pole in particular.2–5 These unique cells were named parietal podocytes and are defined as cells with features of differentiated podocytes lining the inner aspect of Bowman’s capsule (Figure 1A). Using an extended panel of antibodies, Bariety et al. showed that parietal podocytes expressed the same marker proteins as visceral podocytes.1 On electron microscopic images, parietal podocytes mostly form interdigitating foot processes3,6,7 and recruit periglomerular capillaries.8 In patients with membranous GN, parietal podocytes behaved similar to visceral podocytes in that they formed subepithelial deposits on the parietal basement membrane identical to those on the glomerular basement membrane (GBM).5

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Characterization of the early events in the coagulation model. (A) Schematic of a parietal podocyte on Bowman’s capsule forming foot processes (arrow) and recruiting periglomerular capillaries (asterisk). (B and B’) Schematic of the electrocoagulation model. Along the lateral margin of the kidney, a necrotic area is visible after coagulation (arrowheads, right kidney). (C) Immediately after coagulation, a triangular area of necrosis is observed, reaching from the renal cortex into the medulla. (D) Higher magnification of the interface between the coagulated renal tissue (arrow) and remaining parenchyma shows several necrotic tubules 3 days after coagulation (arrowheads) with inflammatory demarcation. (E) After 1 week, multiple tubules are dilated (arrowhead). (F) After 3 weeks, glomeruli with obliterated urinary poles (arrow) and atrophic tubular remnants (arrowheads) are observed. C–F show periodic acid–Schiff stainings of paraffin sections. (G) Immunohistologic double staining shows that cells obstructing the tubular outlet are SSeCKS-positive parietal cells (arrow) and that Bowman’s capsule is lined by parietal podocytes projecting from the vascular pole (arrowheads). (H–I) TUNEL assays consistently show positive nuclear staining in PECs (approximately 1–2 positive nuclei per 100 glomeruli) 1–3 weeks after electrocoagulation (G, arrow). (H) No nuclear staining is observed in healthy controls.

The number of parietal podocytes on Bowman’s capsule may vary significantly. Published data indicate that their number increases throughout life.9 In normal kidneys, parietal podocytes are rare,1 whereas their frequency and number is increased in transplant nephrectomies and in diseased kidneys.2,5 In atubular glomeruli or glomerular cysts, parietal podocytes can often be found on Bowman’s capsule—in many cases, covering its entire circumference.1,7,10–12 Atubular glomeruli and glomerular cysts are not uncommon even in “normal kidney tissue” obtained from tumor nephrectomies (up to 1% of all glomeruli).10,13 Both are particularly common, however, in renal diseases affecting the tubulointerstitium.14–19 Furthermore, atubular/cystic glomeruli have also been observed in other renal diseases,20 including diabetic nephropathy in which on average 17% of all glomeruli were atubular,13 transplanted kidney affected by chronic allograft rejection (60% atubular glomeruli),10 severe renal artery stenosis (50% atubular glomeruli),21 GN,5,10 pyelonephritis,14 and polycystic kidney disease.22,23 Glomerular cysts lined by parietal podocytes have also been described in different cystic diseases in animals.7,11,12,24

In previous studies, it was proposed that parietal epithelial cells (PECs) may differentiate into podocytes acting as a potential intrinsic progenitor cell population.25,26 Parietal podocytes provide a unique and exceptional situation to investigate whether PECs have the potential to transdifferentiate into podocytes in situ on Bowman’s capsule. In this study, we set out to resolve the origin of parietal podocytes by lineage tracing. For this purpose, a novel model to induce the generation of parietal podocytes in atubular glomeruli was established.

Results

Glomerular Detubularization by Electrocoagulation

Because parietal podocytes were reported to occur predominantly in atubular glomeruli (i.e., in glomeruli that had been disconnected from their tubule), we first developed a novel model to induce atubular glomeruli in adult mice. In this model, short electrocoagulation pulses were applied via a thin needle inserted in different locations into the cortex of the right kidney (Figure 1, B and B’). Subsequent light microscopic examinations at different time points thereafter documented the classic chronology of tubular loss (Figure 1, C–F). Focal disruption of the tubular integrity, tubular necrosis, and infiltrating inflammatory cells were observed. Renal tissue distant from the coagulation site appeared unaffected. Seven days after coagulation, dilated tubules and interstitial infiltrating cells were found throughout the kidneys (Figure 1E). These pathologic findings were observed not only in the vicinity of the coagulation but also in areas more distant to the primary damage. Three weeks after coagulation, multiple atubular glomeruli were apparent (Figure 1F), in which the tubuloglomerular junction was obstructed by a cellular mass that consisted predominantly of SSeCKS-positive parietal cells (Figure 1G, see below). Terminal deoxynucleotidyl transferase–mediated digoxigenin-deoxyuridine nick-end labeling (TUNEL)–positive nuclei could be detected in PECs after 1, 2, and 3 weeks (1–2 TUNEL-positive PECs in 100 random glomerular cross-sections per animal) (Figure 1, H and I). This effect could not have been a consequence of doxycycline administration because TUNEL-positive PECs were not observed in a previous study in control mice.27

Characterization of the Coagulation Model to Induce Atubular Glomeruli

For a detailed characterization of the novel model of detubularization by electrocoagulation, a total of 80 mice were treated under different conditions. Atubular glomeruli developed in all mice independent of genetic background (Sv129 or C57Bl/6), sex, or age of the mice at coagulation (3 weeks versus 20 weeks of age) (Figure 2, A–E and G–J). Serial sections revealed that the urinary poles of all glomerular cysts were obstructed and had degenerated. In addition, cystic dilation of atubular glomeruli (“large glomerular cysts”) was observed particularly in Sv129 mice (Figure 2, A–C and K). The larger cysts reached a diameter of 500–750 μm (Figure 2B). Sv129 mice coagulated at a younger age and those analyzed 6 months after coagulation showed the highest percentage of dilated large cystic glomeruli (Figure 2K).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Characterization of the coagulation model. (A) Atubular glomerular cysts (arrowheads) and adjacent intact renal parenchyma (interface highlighted with arrows). (B) Higher magnification of a large glomerular cyst with a characteristic hypotropic tuft (arrowhead). The urinary pole is obstructed by cells and extracellular matrix (arrow). (C) Normal tubules are located immediately adjacent to atrophic, protein-filled tubules (arrow). A–C show periodic acid–Schiff stainings of kidneys from 6-month-old Sv129 mice, electrocoagulated at 3 weeks of age. (D) In C57BL/6 mice, significant cystic dilation of Bowman’s capsule occurs with a lower frequency in atubular glomeruli after electrocoagulation (arrows). (E) The urinary poles of small atubular glomeruli are similarly obstructed (white arrows) and surrounded by atrophic tubules and increased extracellular matrix (arrowheads). (F) The papilla contains mostly atrophic tubules (arrows), whereas other segments still appear unaffected (arrowhead). D–F show periodic acid–Schiff stainings of kidneys from 7-month-old C57BL/6 mice electrocoagulated at age 5 months. (G–J) Influence of the genetic background (38 Sv129 mice versus 36 C57BL/6 mice) (G), the postoperative observation time until euthanasia (30 mice at 2 months versus 44 mice at 6 months) (H), sex (39 female mice versus 35 male mile) (I), and age of the mice at coagulation (37 mice at 3 weeks versus 37 mice at 20 weeks) (J) on the development of glomerular cysts, which are shown as the percentage of glomerular cysts of all glomeruli, with 100 glomeruli per mouse analyzed (+, right coagulated kidney; −, left control kidney). (K) Factors facilitating the formation of larger glomerular cysts (>150 μm) shown as percentage of all glomerular cysts. The highest frequency of larger cysts is observed in Sv129 mice coagulated at 3 weeks of age and euthanized after 6 months (right panel). (L) Ki67-positive cells on Bowman’s capsule were counted in 50 glomeruli of each experimental animal (36 Bl6 mice and 38 Sv139 mice). Most proliferating cells are observed in Sv129 animals, which also develop the largest cysts. *P<0.05; **P<0.01; ***P<0.001.

Within the larger cysts, glomerular cross-sections contained more proliferating cells on Bowman’s capsules (Figure 2L). Because the glomerular tufts were not always obvious in the examined tissue sections and to analyze whether these cysts represent glomerular or tubular cysts, double immunofluorescence staining was performed with synaptopodin, a podocyte marker, and SSeCKS, a protein expressed by PECs28,29 (Figure 3A). All large cysts, with or without a glomerular tuft, showed similar SSeCKS immunostaining of the cells lining the cyst, indicating the presence of PECs. Therefore, the large cysts were glomerular cysts (Figure 3B).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Cysts induced by electrocoagulation are glomerular cysts. (A) In normal glomeruli, synaptopodin (A, arrow) and SSeCKS (A’, arrow) are specifically detected in podocytes and PECs, respectively. The boundary from synaptopodin-positive podocytes and SSeCKS-positive PECs is at the VP (arrow). (B) Overview kidney section from a 6-month-old Sv129 mouse coagulated at 3 weeks of age containing a normal segment and a segment containing atubular and cystic glomeruli costained for synaptopodin and SSeCKS. Both cysts with (arrows) and without (asterisks) a visible glomerular tuft show expression of the PEC marker SSeCKS, indicating that all represent glomerular cysts. (C) Synaptopodin expression is observed on Bowman’s capsule in multiple atubular glomerular cysts (arrows). These parietal podocytes are negative for SSeCKS (C’, arrows). In these glomeruli, the boundary between podocytes and PECs shifts from the vascular stalk onto Bowman’s capsule (3C”, arrowheads). VP, vascular pole; UP, urinary pole.

Parietal Podocytes in Atubular Glomeruli

Synaptopodin immunostaining revealed synaptopodin-positive cells lining Bowman’s capsule of atubular (cystic) glomeruli (Figure 3C, arrows). PEC marker SSeCKS was absent along segments of Bowman’s capsule covered by synaptopodin-positive cells (Figure 3, C’ and C’’, arrows). In atubular (cystic) glomeruli, the transition from podocytes to PECs was shifted away from the vascular pole (Figure 3, C’ and C’’, arrowheads).

Parietal podocytes identified by the expression of synaptopodin were observed predominantly in the coagulated kidneys and were a rare finding in control kidneys. Within the coagulated kidneys, parietal podocytes were localized exclusively within atubular (cystic) glomeruli regardless of the glomerular size, but were not observed in normal glomeruli of the same kidney (Figure 4, A and B). Parietal podocytes occurred in approximately 40%–45% of all glomerular cross-sections (counting all glomeruli, tubular or atubular) irrespective of genetic background, time since coagulation, sex, or age at intervention (Figure 4, C–F).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Parietal podocytes in atubular glomeruli. (A and B) Bowman's capsules of atubular glomeruli are lined by synaptopodin-positive parietal podocytes regardless of the cyst diameter. (C–F) Influence of genetic background (38 Sv129 mice versus 36 C57BL/6 mice) (C), postoperative observation time until euthanasia (30 mice at 2 months versus 44 mice at 6 months) (D), sex of the mice (39 female mice versus 35 male mice) (E), or age at coagulation (37 mice at 3 weeks versus 37 mice at 20 weeks) (F) on the frequency of atubular glomeruli with parietal podocytes. The y-axis shows the percentage of glomeruli with synaptopodin-positive cells on Bowman’s capsule versus all glomeruli on a renal cross-section, with 50 glomeruli per mouse analyzed. *P<0.05; **P<0.01; ***P<0.001.

By transmission electron microscopy, parietal podocytes exhibited typical podocyte features such as large lobulated nuclei and interdigitating foot processes (Figure 5), regardless of the glomerular size. Not all parietal podocytes were fully differentiated and some showed a flattened appearance and partial foot process effacement, particularly in the unilateral ureter obstruction (UUO) model (see below). A potential explanation for this difference might be that parietal podocytes were analyzed after 6 months in the coagulation model versus 3 weeks in the UUO model. Occasionally, podocytes projected foot processes onto Bowman’s capsule as well as onto the glomerular tuft (Figure 5C). This was also observed in normal human kidney (Supplemental Figure 1).

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Ultrastructure of atubular glomeruli. (A) Transmission electron microscopic images of an atubular glomerulus forming a glomerular cyst. Parietal podocyte differentiation varies along Bowman’s capsule, with areas of partial foot process effacement (arrow) between areas with interdigitating foot processes (arrowheads). (B) At higher magnification, a parietal podocyte forms interdigitating foot processes (arrowhead), resides on a thin GBM-like basement membrane, and recruits a periglomerular capillary indicating vascular endothelial growth factor expression (arrow). (C) A podocyte adheres to the glomerular tuft as well as to Bowman’s capsule forming foot processes on both sides (arrowheads).

Tracing Podocytes or PECs in Atubular Glomeruli

The origin of parietal podocytes was determined by lineage tracing.25,30–32 For this purpose, podocytes or PECs were irreversibly genetically tagged for 14 days using doxycycline including a wash-out phase of at least 7 days in triple transgenic Pod-rtTA/LC1/R26R30 or PEC-rtTA/LC1/R26R25 mice, respectively. After induction of atubular glomeruli by coagulation, animals were euthanized after 2 or 6 months and serial kidney sections were stained either for the genetic tag (β-galactosidase [β-gal]) (Figure 6, A1, A3, B1) or nephrin (Figure 6, A2, A4, B2), which is expressed exclusively by differentiated podocytes in the kidney.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Lineage tracing of podocytes or PECs in atubular glomeruli. (A1–A4) Serial cryosections of a triple transgenic Pod-rtTA/LC1/R26R mouse kidney (coagulation at 6 weeks of age and euthanasia at 6 months later). (A1 and A3) Genetically tagged podocytes are visualized using β-gal staining. (A2 and A4) Differentiated podocytes are stained in brown (antinephrin). In these serial sections, the same areas of Bowman’s capsule costain for β-gal and nephrin, indicating the presence of differentiated visceral podocytes on Bowman’s capsule (same arrows in consecutive sections indicate colocalization). (B1 and B2) Serial cryosections of a transgenic Pec-rtTA/LC1/R26R mouse kidney (coagulation at 6 weeks of age, euthanized 6 months later) stained for PEC marker β-gal or nephrin, respectively. In the vicinity of the vascular pole, genetically tagged PECs can no longer be found on Bowman’s capsule (B1, arrows). Instead, differentiated podocytes are detected, which are not derived from PECs (B2, arrows). (C) A parietal podocyte with multiple differentiated foot processes on Bowman’s capsule (arrowheads) is marked by the genetic marker for podocytes (black deposits of Bluo-Gal in a Pod-rtTA mouse). Similar Bluo-Gal deposits can be observed on the visceral podocyte on the glomerular tuft (arrows with tail).

Tracing of podocytes in atubular glomeruli revealed the appearance of genetically tagged podocytes on Bowman’s capsule (Figure 6, A1–A4). In cells lining Bowman’s capsule, nephrin was expressed exclusively by genetically tagged podocytes. In normal glomeruli, no β-gal or nephrin expression was observed on Bowman’s capsule (not shown). Genetically labeled PECs were detected exclusively on Bowman’s capsule in both normal and atubular glomeruli. In atubular glomeruli, genetically tagged PECs were found next to parietal podocytes (Figure 6, B1 and B2). In summary, these findings show that parietal podocytes originate from differentiated visceral podocytes migrating onto the Bowman’s capsule. By transmission electron microscopy using Bluo-Gal staining (forming an insoluble intracellular black precipitate in cells expressing β-gal), capsules of atubular glomeruli were shown to contain genetically tagged podocytes with a typical podocyte phenotype, confirming our results (Figure 6C).

Formation of Parietal Podocytes in Atubular Glomeruli in the UUO Model

We next assessed the UUO model, which results in synchronized formation of atubular glomeruli in the entire kidney.33 After UUO, the glomerular architecture remains largely preserved.34 Three weeks after UUO, marked tubular damage, interstitial cellular infiltration, and formation of atubular glomeruli with obstruction of the urinary pole by a cellular layer were observed (Figure 7, A and B, arrowheads). Staining for the podocyte markers synaptopodin and nephrin revealed parietal podocytes on Bowman's capsule (Figure 7, C–G). Serial cryosections stained for β-gal or nephrin in the triple transgenic Pod-rtTA/LC1/R26R mice confirmed migration of visceral podocytes as the origin of parietal podocytes (Figure 7, E–E’). Again, TUNEL-positive nuclei were observed in PECs 7 days after UUO indicating apoptosis or necrosis of these cells (Figure 7H).

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Lineage tracing of parietal podocytes in the UUO model. (A) Typical morphologic changes are observed 3 weeks after UUO on sections stained with periodic acid–Schiff. These include degeneration of renal medulla (black arrows), dilated proximal tubules with protein casts (white arrows), and atubular glomeruli (arrowheads). (B) Degeneration of the glomerulotubular junction. A thin basement membrane with a layer of cubic cells (arrowheads) has disconnected the proximal tubule (arrow). (C–D’) Three weeks after UUO, the Bowman’s capsule of the atubular glomeruli is lined by synaptopodin- and nephrin-positive parietal podocytes (arrows). (E and E’) Serial cryosections of a Pod-rtTA/LC1/R26R mouse show colocalization of β-gal and nephrin staining in parietal podocytes 3 weeks after UUO (arrows). (F) Statistical analysis of the percentage of glomeruli with synaptopodin-positive cells on Bowman’s capsule 1–3 weeks after UUO (12 mice total, 50 glomeruli per time point). Using ANOVA and Bonferroni analysis, no statistically significant differences are observed between experimental animals over time. (G) Negative control for nephrin immunostaining using irrelevant guinea pig antiserum as a primary antibody shows no reactivity. (H) Seven days after UUO, nuclear TUNEL staining is observed in PECs (arrows; SSeCKS, TUNEL, Hoechst triple staining). Nonspecific green fluorescence arises from erythrocytes in glomerular and tubulointerstitial capillaries. ***P<0.001.

Atubular Glomeruli in Human Kidney

First, the normal expression pattern of synaptopodin, claudin-1, was examined in normal kidneys, one of which was a kidney from an 18-year-old healthy individual (who died in a car accident). Synaptopodin and claudin-1 did not colocalize and were expressed exclusively by cells on the glomerular tuft or on Bowman’s capsule, respectively (Figure 8, A–A’’). Twelve human kidneys were evaluated for atubular glomeruli on serial sections (four and eight kidneys with or without renal pathologies, respectively). In atubular glomeruli, podocyte marker synaptopodin was expressed by cells lining Bowman’s capsule, indicating the presence of parietal podocytes, close to the vascular pole in particular (Figures 8, C–E’’, and 9). PEC marker claudin-1 was not detected, indicating that PECs were absent (Figure 8, B–B’’’). Interestingly, no overlap or colocalization of podocyte marker synaptopodin and PEC marker claudin-1 was observed in atubular glomeruli lined partially by parietal podocytes. In approximately 15% of all glomeruli of diseased kidneys, the entire Bowman’s capsule was lined by synaptopodin-positive parietal podocytes (Figure 9). In these glomeruli, claudin-1 expression was not detectable (Figure 8, C–C’’). Costaining for the marker synaptopodin and the PEC marker CD133 also did not show any overlap (Figure 8, D–E’’). As a side finding, approximately 30%–40% of all glomeruli show few parietal podocytes (located mostly close to the vascular pole) even in healthy human kidneys (Figure 9). This finding suggests that the boundary between podocytes and parietal cells may shift somewhat (a similar finding is also shown in Supplemental Figure 1).

Figure 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8.

Podocyte and PEC marker expression in humans. (A–A’’’) Immunofluorescence double stainings of an apparently normal kidney of an 18-year-old old healthy man show no colocalization of the podocyte marker synaptopodin and the PEC marker claudin-1 on Bowman’s capsule. (B–E’’) Sporadic atubular glomeruli in human kidneys. Synaptopodin-positive parietal podocytes (arrowhead in B) does not show costaining for the PEC marker claudin-1 in atubular glomeruli (arrowheads in B’ and B’’). A sharp border between synaptopodin and claudin-1–stained cells is always observed in atubular glomeruli (B’’, arrowhead). Atubular glomeruli in which the entire Bowman’s capsule stained for synaptopodin are negative for claudin-1 (C–C’’, arrows). (D–E’’) Similarly, no costaining for synaptopodin (podocytes) and CD133 (PECs) is observed in glomeruli in which Bowman’s capsule is totally (D) or partially (E) lined by synaptopodin-positive parietal podocytes.

Figure 9.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 9.

Statistical analysis of the proportion of Bowman’s capsules covered by synaptopodin-positive cells (presumptive parietal podocytes). More than half of the glomeruli do not show parietal podocytes. In a significant portion of glomeruli (approximately 30%–40%), few parietal podocytes are detected (mostly close to the vascular pole, indicating that minor shifts of the podocyte to parietal cell interface occur in human kidneys over time). Bowman’s capsules populated more than one third by parietal podocytes occur predominantly in diseased kidneys and represent atubular glomeruli. Four and eight total kidney specimens with or without renal pathologies, including all 1404 random cross-sections of individual glomeruli, are analyzed.

Discussion

As outlined in the introduction, atubular glomeruli and glomerular cysts can be observed in a wide range of renal diseases. This study sheds light on the pathogenesis: Tubular injury resulting in permanent loss of the affected tubule may be a major mechanism by which atubular glomeruli are formed in human kidneys. Thus, the frequency of atubular glomeruli may indicate the sum of tubular losses within an individual kidney.

In this study, we first established a new model to induce atubular glomeruli in adult kidneys in experimental mice. A systematic characterization showed that this induced the formation of large glomerular cysts in some animals. Formation of larger glomerular cysts was determined by the age at disease induction, the length of the postoperative observation period until euthanasia, and the genetic background. The results of this study are in good agreement with previous observations that fetal urinary obstruction results in glomerular cyst formation.20,35 In addition, it has been shown that glomerular cysts can be induced by high-dose corticosteroid injections into newborn rabbits.12,36 In this study, we show that formation of glomerular cysts is also feasible in adult animals and that glomerular cysts can result from renal pathologies acquired in adult life.

What triggers the cystic enlargement of atubular glomeruli? We previously described the Pax8-Cre/β-cateninfl/fl mouse in which Bowman’s capsules are lined by fully differentiated parietal podocytes and not by PECs.8 We showed that inactivation of β-catenin during renal development causes glomerular epithelial cell precursors on Bowman’s capsule to differentiate toward the podocyte lineage. Of note, these glomeruli formed large cysts but were not atubular. These findings argue against the notion that blocked filtration and subsequently raised intraglomerular pressures mediate dilation of atubular glomeruli into cysts.24 Rather, the presence of parietal podocytes on Bowman’s capsule appears to be a critical prerequisite for glomerular cyst formation.

The second major and surprising finding of this study is that parietal podocytes originate from visceral podocytes migrating from the vascular pole onto Bowman’s capsule (summarized in Figure 10). Using irreversible genetic tagging, it became possible to trace podocytes or PECs after induction of atubular glomeruli for the first time. Three possible explanations for the origin of parietal podocytes have been discussed in the literature over the years: (1) evagination of the capillary tuft, due to high intraglomerular pressures24; (2) direct transdifferentiation of PECs toward a podocyte phenotype25,26,36; or (3) migration of podocytes from the tuft.2 The first explanation of evagination involves unfolding or spreading of the glomerular tuft along the Bowman’s capsule due to the enlargement of the Bowman’s space. By this process, it is inferred that segments of the glomerular tuft become an integral part of Bowman’s capsule. This mechanism would be consistent with the finding that the largest glomerular cysts usually contain the smallest and most rudimentary tuft remnants, consistent with previous studies.37–39 Our study cannot exclude evagination as one of the processes leading to the parietal podocytes in the glomerular cysts. Nonetheless, in the “normal sized” atubular glomeruli that were analyzed in both models, parietal podocytes were also present on Bowman’s capsule despite the lack of cystic glomerular enlargement. The fact that the size of the glomerular cyst is inversely correlated with the size of the glomerular tuft is also consistent with the third explanation that visceral podocytes migrate onto Bowman’s capsule. In the largest cysts, there might be an increased demand of podocytes to cover the inner aspect of Bowman’s capsule. As a consequence, more podocytes will be recruited away from the glomerular tuft onto Bowman’s capsule. Finally, as already outlined above, glomerular cyst formation does not require increased intraglomerular pressures.8

Figure 10.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 10.

Schematic for the origin of parietal podocytes. In atubular glomeruli, the urinary outlet is disconnected from the tubule (orange) by a layer of epithelial cells (blue, PECs and/or proximal tubular cells) forming their own basement membrane (arrowhead) and becomes obstructed. PECs (blue) are progressively lost and visceral podocytes (green) migrate from the capillary tuft onto Bowman’s capsule via the vascular stalk to become parietal podocytes (arrow).

The second explanation is that PECs have the capacity to transdifferentiate into podocytes on Bowman’s capsule. Podocytes are an essential part of the glomerular filtration barrier but cannot regenerate themselves.40,41 Loss of podocytes beyond a certain threshold is sufficient to trigger glomerulosclerosis.42,43 We recently showed that late in renal development, a fraction of podocytes are recruited from cells on Bowman’s capsule (presumptive PECs),25 offering the perspective that this mechanism might still be preserved in adults.26 However, the lineage tracing experiments of this study in adult mice showed no evidence for transdifferentiation of PECs to a podocyte phenotype in atubular glomeruli, ruling out the second explanation in this specific situation. This is consistent with lineage tracing studies of two research groups (including ourselves) in adult mice during aging or after induction of progressive glomerular hypertrophy. Under these circumstances, as in this study, no recruitment of podocytes from parietal cells was observed (Berger et al. and Wanner et al., unpublished data). However, we did confirm our earlier findings that podocytes are recruited from cells of Bowman’s capsule in newborn mice after the capillary loop stage.25 These results indicate that some cells on Bowman’s capsule differentiate directly into podocytes, likely forming a small reserve of podocytes (10% at the most) that are recruited onto the glomerular tuft as the glomeruli undergo physiologic hypertrophy during adolescence.

It was recently proposed that in normal glomeruli of human kidneys, parietal podocytes may form close to the vascular pole as a result of progressive differentiation of CD133- and CD24-positive PECs acting as a potential regenerative cell population for visceral podocytes.26,44 The hypothesis describing differentiation of PECs into new podocytes is based to a large extent on the observation of a gradient in the expression of differentiation markers. Specifically, toward the vascular pole, CD133- and CD24-positive PECs were described to coexpress the presumptive podocyte marker proteins podocalyxin, nestin, and WT-1. Further along, mature podocytes progressively lost the expression of the PEC “progenitor” markers CD133 and CD24, resulting in a gradient of differentiating cells. These observations were all done in human kidneys. In this study, we analyzed the expression of the PEC markers claudin-1 and CD133 and the podocyte marker synaptopodin in the human kidneys. In our hands, the transition from parietal podocytes to PECs was abrupt, supporting that PECs and parietal podocytes are distinct cell populations. Of note, because the origin of parietal podocytes was anayzed in this study by lineage tracing in cystic and/or atubular glomeruli exclusively, these results do not rule out the previously postulated regeneration of podocytes by PECs under physiologic conditions.25,26

The major finding of this study is that visceral podocytes may migrate from the glomerular tuft onto Bowman’s capsule. This concept is very surprising and unexpected. Thus far, podocytes have only been proven to migrate onto Bowman’s capsule in the context of an acute inflammatory nephritis such as rapidly progressive GN (RPGN).31,45–47 In RPGN, podocytes dedifferentiate and migrate via direct adhesions onto Bowman’s capsule. There they contribute to the formation of cellular crescents by proliferation together with activated PECs. In this study, we show for the first time that fully differentiated podocytes may also leave the glomerular tuft. In contrast to RPGN, the exodus of podocytes occurred via the vascular stalk. In this study, the boundary between podocytes and PECs may shift significantly from the vascular stalk onto Bowman’s capsule. In normal glomeruli of human kidneys, parietal podocytes could often be observed close to the vascular pole and in continuity to the visceral podocytes, suggesting that the boundary between the two cell types may shift gradually over time. Isolated patches of labeled parietal podocytes were rarely observed,1 supporting the observation that the vascular stalk is the major route of differentiated podocytes onto Bowman’s capsule.

Progressive loss of PECs in atubular glomeruli could be a potential trigger for differentiated podocytes to migrate onto Bowman’s capsule. Sporadic TUNEL-positive nuclei were consistently observed in PECs. PECs are ciliated cells, similar to tubular epithelial cells, whereas podocytes do not form a primary cilium.6,48 It has been proposed that tubular cells require the urinary flow, which is sensed by the primary cilium, for survival.49–51 Tubular cells—as well as PECs, as suggested by our findings—may become apoptotic/necrotic after interruption of the urinary flow by electrocoagulation or UUO. We propose that the decreasing number of PECs on Bowman’s capsule might represent the stimulus for visceral podocytes to migrate from the capillary tuft and populate Bowman’s capsule. Both cell populations are in direct contact so that migration of podocytes might be mediated by “disinhibited” lateral contact inhibition (similar to the wound healing assay in in vitro systems).

In summary, this study revealed a surprising and unexpected finding in atubular glomeruli, which is opposite to what was previously generally believed. Differentiated podocytes may migrate from the glomerular tuft via the vascular pole onto Bowman’s capsule.

Concise Methods

Transgenic Mice

PEC-rtTA/LC1/R26R and POD-rtTA/LC1/R26R transgenic mice were previously described.25,30,52 Animals were housed under standard specific pathogen-free conditions, including a 12-hour light cycle. All animal procedures were approved by the local authorities (LANUV NRW, AZ 8.87-51.04.20.09.345).

Doxycycline Treatment

The PEC-rtTA and the POD-rtTA animals received doxycycline hydrochloride via the drinking water ad libitum for a total of 14 days (5% sucrose, 0.5 mg doxycycline/ml, protected from light), which was exchanged every 2 days. To be sure that the mice were free from doxycycline during the experimental procedures, the mice received normal drinking water ad libitum for at least 7 days.

Electrocoagulation Model

Twelve 3-week-old Sv129 mice (equal sex distribution) underwent the following procedure. Mice were anesthetized with ketamine-xylazine (100 mg/ml ketamine and 20 mg/ml xylazine in normal saline 0.9%; 0.1 ml per 10 g of body weight) and positioned on a counter electrode. Afterward mice were shaved and disinfected and a laparotomy was performed. The intestine was mobilized and the right renal capsule was removed. A thin needle was then injected in the renal margin into a depth of approximately 3–4 mm, and an electrical current was subsequently applied along the needle using an electrosurgical unit. This was repeated five times in regular distances. The left kidney remained unaltered. After the intervention, the mice were treated with buprenorphine for 3 days (0.05–0.1 mg/kg subcutaneously). Mice were euthanized after 3, 7, 14, and 21 days and renal tissue was preserved for microscopic examination. For characterization of the model, 3-week-old Sv129 and Bl6 mice (n=20 each, equal sex distribution) and 20-week-old Sv129 and Bl6 mice (n=20 each, equal sex distribution) were subjected to electrocoagulation as described above (Charles River Laboratories International Inc., Wilmington, MA). Mice were euthanized as shown in Table 1.

Six-week-old PEC-rtTA/LC1/R26R (n=18) and POD-rtTA/LC1/R26R (n=10) transgenic mice were electrocoagulated as described above and euthanized 2 or 6 months later.

View this table:
  • View inline
  • View popup
Table 1.

Characteristics of the study mice

UUO

Six-week-old POD-rtTA (n=12), LC1, R26R transgenic mice a complete UUO of the right kidney was performed. Animals were anesthetized as mentioned above, and the ureter was exposed by a median laparotomy and then ligated with 8-0 nylon. One third of the animals (n=4) were euthanized after 1, 2, and 3 weeks, respectively.

Perfusion Fixation

Mice were anesthetized (ketamine/xylazine) and perfused with 3% paraformaldehyde in PBS (pH 7.4) via the left ventricle for 3 minutes. Pieces of both kidneys were snap-frozen in Tissue-Tek (Miles Inc., Iowa City, IA), postfixed in 3% buffered formalin for 24 hours, and embedded in paraffin.

Light Microscopy

Four-micrometer paraffin sections were stained with periodic acid–Schiff. β-gal expression was visualized using enzymatic X-gal staining. For this purpose, 4- to 6-µm cryosections were incubated overnight at 37°C in a humidified atmosphere in staining solution (1 mg/ml X-gal, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM MgCl2 in PBS pH 7.8). The next day, samples were stained with eosin, washed in tap water, and mounted (Immu-Mount; Thermo Scientific, Waltham, MA).

Immunofluorescence and immunohistochemical stainings were performed on renal paraffin and cryosections. For the single and double staining, the paraffin sections were rehydrated in PBS and subjected to microwave heating (3×5 minutes at 600 W with Antigen unmasking solution; Vector Laboratories, Burlingame, CA). Sections were incubated with the following primary antibodies: rabbit anti-claudin-1 (1:50, RB-9209-P1; Thermo Fisher), goat anti-synaptopodin (1:100, sc-50459; Santa Cruz Biotechnology, Santa Cruz, CA), mouse anti-synaptopodin (1:50, 65294; Progen, Brisbane, Australia), rabbit anti-SSeCKS (1:100; Irwin H. Gelman Laboratory, Roswell Park Cancer Institute, Buffalo, NY), rabbit anti-Ki67 (1:100, ab166667; Abcam, Cambridge, UK), and guinea pig anti-nephrin (1:400, GP-N2; Progen). The following secondary antibodies were used for immunofluorescence: DyLight 488 anti-rabbit (1:200, 711-485-152; Dianova, New Paltz, NY), DyLight 549 anti-mouse (1:200, 715-505-151; Dianova), goat anti-rabbit Cy-3 (1:200, 711-165-152; Dianova), and donkey anti-rabbit Alexa Fluor 647, 1:200, 711-605-152, Dianova). Slides were counterstained with Hoechst 33258 (Molecular Probes, Darmstadt, Germany) to stain nuclei. The following secondary antibodies were used for immunohistochemistry: biotinylated anti-guinea pig IgG (1:300, BA-7000; Vector Labs, Burlingame, CA) and biotinylated anti-rabbit IgG (1:300, BA-1000; Vector Labs). The Vectastain ABC kit (Vector Labs) and the Vector Peroxidase Substrate kit (SK-4100; Vector Labs). For nucleus staining, slides were counterstained using Mayer's hemalaun solution (Merck, Darmstadt, Germany). The Apoptosis Detection Kit S7111 was used (Chemicon International Inc, Temecula, CA) for TUNEL staining. Sections were evaluated with a Leica DMRX microscope (Leica, Wetzlar, Germany). Images were collected with Diskus (Diskus Kameras, Koenigswinter, Germany) and prepared for presentation with Adobe Photoshop CS5 and Illustrator CS5 software (Adobe Systems, Mountain View, CA).

Transmission Electron Microscopy

For transmission electron microscopy, 2×2 mm pieces of the kidneys were either postfixed in Karnovsky fixative, processed, and embedded into Epon using standard procedures, or they were fixed in 3% glutaraldehyde solution for 1 hour, subsequently incubated in Bluo-Gal solution at 37°C overnight, and were then treated as mentioned above.

Human Renal Tissue

Human renal tissues were sourced from the database of the Institute of Pathology in Aachen and one unused transplant kidney from the School of Physiology and Pharmacology, University of Bristol (Bristol, UK). Use of these tissues was approved by the local ethics committee in both countries. We used specimens of kidneys with recurrent pyelonephritides because tubular destruction in this disease often leads to atubular glomeruli. The details on each specimen are listed in Tables 2 and 3.

View this table:
  • View inline
  • View popup
Table 2.

Nephrectomies or renal biopsies (no needle biopsies) with normal histopathologic appearance

View this table:
  • View inline
  • View popup
Table 3.

Nephrectomies with pathologic findings

Evaluation of Glomerular Cysts

At least 50 glomeruli of each experimental animal were evaluated on random transverse sections through the kidney. Cavities with a diameter >100 µm and without a glomerular tuft were counted only when the capsule was typical for an atubular glomerulus. Glomeruli with an obvious Bowman’s space and a diameter of >100 µm and <150 µm were categorized as small glomerular cysts. Glomeruli with a diameter >150 µm were categorized as large glomerular cysts.

Serial Block Face Scanning Electron Microscopy of Human Glomeruli

An unused transplant kidney was perfused with transport solution (Soltran) and transported on ice. Renal arteries were cannulated and perfused (100 mmHg hydrostatic pressure) with a mammalian HEPES Ringer solution containing Ficoll 400 as an oncotic balance (25 mmHg colloid osmotic pressure). This was replaced with a glutaraldehyde fixative solution at the same pressures. Kidney tissues were fixed and loaded with heavy metals en bloc using osmium teroxide, osmium ferrocyanide, thiocarbohydrazide, osmium tetroxide, uranyl acetate, and lead aspartate, and then dehydrated and embedded in a hard formulation resin. Blocks of tissue were trimmed to one glomerulus and this was mounted in a Serial Block Face Scanning Electron Microscope set to take 500 sections at 150-nm thick (total 75-µm depth) and image the block face at each section level. Image stacks were manipulated using ImageJ software (National Institutes of Health, Bethesda, MD).

Evaluation of Synaptopodin Staining

Fifty glomeruli of each experimental animal on random transverse sections through the kidney were analyzed. All of those glomeruli (also those without a cut glomerular tuft) with a synaptopodin positively stained Bowman’s capsule were put into relation to the sum of analyzed glomeruli.

Statistical Analyses

For the electrocoagulation or UUO model in experimental mice, 7400 and 1200 glomeruli were photographed and analyzed, respectively. For lineage tracing, a total of 700 glomeruli were analyzed in serial sections (X-gal/nephrin staining). In human kidneys, 1404 (synaptopodin staining) and 1200 glomeruli (periodic acid–Schiff staining) were analyzed. Data were analyzed using Prism 4.0 software (GraphPad, San Diego, CA) applying the t test or ANOVA and Bonferroni analysis, respectively.

Disclosures

None.

Acknowledgments

This work was supported by grants from the German Research Foundation (TP17 and TP25 SFB/Transregio 57 to P.B., J.F., and M.J.M.; BO 3755/1-1 to B.S. and P.B.), funding from the E-Rare, European Research Projects on Rare Diseases (Project Rare-G #01 GM 1208A to M.J.M), the British Heart Foundation (PG/08/059/25335PB to K.P.A.), and the Richard Bright Research Fund (to C.R.N.). J.F. and M.J.M. are members of the German Research Foundation SFB/TRR57 consortium on Mechanisms of Organ Fibrosis.

Footnotes

  • B.S. and M.J.M. contributed equally to this work.

  • Published online ahead of print. Publication date available at www.jasn.org.

  • This article contains supplemental material online at http://jasn.asnjournals.org/lookup/suppl/doi:10.1681/ASN.2013040376/-/DCSupplemental.

  • Copyright © 2014 by the American Society of Nephrology

References

  1. ↵
    1. Bariety J,
    2. Mandet C,
    3. Hill GS,
    4. Bruneval P
    : Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 17: 2770–2780, 2006pmid:16943305
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Gibson IW,
    2. Downie TT,
    3. More IA,
    4. Lindop GB
    : Tuft-to-capsule adhesions and their precursors: Differences between the vascular and tubular poles of the human glomerulus. J Pathol 184: 430–435, 1998pmid:9664911
    OpenUrlCrossRefPubMed
  3. ↵
    1. Gibson IW,
    2. Downie I,
    3. Downie TT,
    4. Han SW,
    5. More IA,
    6. Lindop GB
    : The parietal podocyte: A study of the vascular pole of the human glomerulus. Kidney Int 41: 211–214, 1992pmid:1593857
    OpenUrlCrossRefPubMed
    1. Ryan GB,
    2. Coghlan JP,
    3. Scoggins BA
    : The granulated peripolar epithelial cell: A potential secretory component of the renal juxtaglomerular complex. Nature 277: 655–656, 1979pmid:423965
    OpenUrlCrossRefPubMed
  4. ↵
    1. Gibson IW,
    2. Downie TT,
    3. More IA,
    4. Lindop GB
    : Immune complex deposition in Bowman’s capsule is associated with parietal podocytes. J Pathol 173: 53–59, 1994pmid:7931837
    OpenUrlCrossRefPubMed
  5. ↵
    Arakawa M, Tokunaga J: A scanning electron microscope study of the human Bowman's epithelium. Contrib Nephrol 6: 73–78, 1977
  6. ↵
    1. Ojeda JL,
    2. Ros A,
    3. García-Porrero JA
    : Structural and morphometric characteristics of the basement membrane of rabbit parietal podocytes induced by corticoids. Acta Anat (Basel) 135: 307–317, 1989pmid:2801003
    OpenUrlCrossRefPubMed
  7. ↵
    1. Grouls S,
    2. Iglesias DM,
    3. Wentzensen N,
    4. Moeller MJ,
    5. Bouchard M,
    6. Kemler R,
    7. Goodyer P,
    8. Niggli F,
    9. Gröne HJ,
    10. Kriz W,
    11. Koesters R
    : Lineage specification of parietal epithelial cells requires β-catenin/Wnt signaling. J Am Soc Nephrol 23: 63–72, 2012pmid:22021707
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Chevalier RL,
    2. Forbes MS
    : Generation and evolution of atubular glomeruli in the progression of renal disorders. J Am Soc Nephrol 19: 197–206, 2008pmid:18199796
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Gibson IW,
    2. Downie TT,
    3. More IA,
    4. Lindop GB
    : Atubular glomeruli and glomerular cysts—a possible pathway for nephron loss in the human kidney? J Pathol 179: 421–426, 1996pmid:8869291
    OpenUrlCrossRefPubMed
  10. ↵
    1. Ramos-Vara JA,
    2. Miller MA,
    3. Ojeda JL,
    4. Reid R,
    5. Craft D,
    6. Watson GL
    : Glomerulocystic kidney disease in a Belgian Malinois dog: An ultrastructural, immunohistochemical, and lectin-binding study. Ultrastruct Pathol 28: 33–42, 2004pmid:14967597
    OpenUrlCrossRefPubMed
  11. ↵
    1. Ojeda JL,
    2. García-Porrero JA
    : Structure and development of parietal podocytes in renal glomerular cysts induced in rabbits with methylprednisolone acetate. Lab Invest 47: 167–176, 1982pmid:7109541
    OpenUrlPubMed
  12. ↵
    1. Najafian B,
    2. Kim Y,
    3. Crosson JT,
    4. Mauer M
    : Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy. J Am Soc Nephrol 14: 908–917, 2003pmid:12660325
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Marcussen N,
    2. Olsen TS
    : Atubular glomeruli in patients with chronic pyelonephritis. Lab Invest 62: 467–473, 1990pmid:2332970
    OpenUrlPubMed
    1. Marcussen N
    : Atubular glomeruli and the structural basis for chronic renal failure. Lab Invest 66: 265–284, 1992pmid:1538583
    OpenUrlPubMed
  14. Marcussen N: Atubular glomeruli in chronic renal disease. Curr Top Pathol 88: 145–174, 1995
  15. Marcussen N: Tubulointerstitial damage leads to atubular glomeruli: Significance and possible role in progression. Nephrol Dial Transplant 15(Suppl 6): 74–75, 2000
    1. Chung WY,
    2. Nast CC,
    3. Ettenger RB,
    4. Danoviton GM,
    5. Ward HJ,
    6. Cohen AH
    : Acquired cystic disease in chronically rejected renal transplants. J Am Soc Nephrol 2: 1298–1301, 1992pmid:1627755
    OpenUrlAbstract
  16. ↵
    1. Bohle A,
    2. Kressel G,
    3. Müller CA,
    4. Müller GA
    : The pathogenesis of chronic renal failure. Pathol Res Pract 185: 421–440, 1989pmid:2690036
    OpenUrlCrossRefPubMed
  17. ↵
    1. Lennerz JK,
    2. Spence DC,
    3. Iskandar SS,
    4. Dehner LP,
    5. Liapis H
    : Glomerulocystic kidney: One hundred-year perspective. Arch Pathol Lab Med 134: 583–605, 2010pmid:20367310
    OpenUrlPubMed
  18. ↵
    1. Marcussen N
    : Atubular glomeruli in renal artery stenosis. Lab Invest 65: 558–565, 1991pmid:1753705
    OpenUrlPubMed
  19. ↵
    1. Grantham JJ,
    2. Geiser JL,
    3. Evan AP
    : Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int 31: 1145–1152, 1987pmid:3599654
    OpenUrlCrossRefPubMed
  20. ↵
    1. Rizzoni G,
    2. Loirat C,
    3. Levy M,
    4. Milanesi C,
    5. Zachello G,
    6. Mathieu H
    : Familial hypoplastic glomerulocystic kidney. A new entity? Clin Nephrol 18: 263–268, 1982pmid:7151342
    OpenUrlPubMed
  21. ↵
    1. Miyoshi M,
    2. Ogawa K,
    3. Shingu K,
    4. Omagari N
    : Scanning and transmission electron microscopy of cysts in the renal cortex of the macaque monkey. Arch Histol Jpn 47: 259–269, 1984pmid:6497590
    OpenUrlCrossRefPubMed
  22. ↵
    1. Appel D,
    2. Kershaw DB,
    3. Smeets B,
    4. Yuan G,
    5. Fuss A,
    6. Frye B,
    7. Elger M,
    8. Kriz W,
    9. Floege J,
    10. Moeller MJ
    : Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 20: 333–343, 2009pmid:19092119
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Ronconi E,
    2. Sagrinati C,
    3. Angelotti ML,
    4. Lazzeri E,
    5. Mazzinghi B,
    6. Ballerini L,
    7. Parente E,
    8. Becherucci F,
    9. Gacci M,
    10. Carini M,
    11. Maggi E,
    12. Serio M,
    13. Vannelli GB,
    14. Lasagni L,
    15. Romagnani S,
    16. Romagnani P
    : Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 20: 322–332, 2009pmid:19092120
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Sicking EM,
    2. Fuss A,
    3. Uhlig S,
    4. Jirak P,
    5. Dijkman H,
    6. Wetzels J,
    7. Engel DR,
    8. Urzynicok T,
    9. Heidenreich S,
    10. Kriz W,
    11. Kurts C,
    12. Ostendorf T,
    13. Floege J,
    14. Smeets B,
    15. Moeller MJ
    : Subtotal ablation of parietal epithelial cells induces crescent formation. J Am Soc Nephrol 23: 629–640, 2012pmid:22282596
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Nelson PJ,
    2. Moissoglu K,
    3. Vargas J Jr,
    4. Klotman PE,
    5. Gelman IH
    : Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells. J Cell Sci 112: 361–370, 1999pmid:9885289
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Burnworth B,
    2. Pippin J,
    3. Karna P,
    4. Akakura S,
    5. Krofft R,
    6. Zhang G,
    7. Hudkins K,
    8. Alpers CE,
    9. Smith K,
    10. Shankland SJ,
    11. Gelman IH,
    12. Nelson PJ
    : SSeCKS sequesters cyclin D1 in glomerular parietal epithelial cells and influences proliferative injury in the glomerulus. Lab Invest 92: 499–510, 2012pmid:22249313
    OpenUrlCrossRefPubMed
  27. ↵
    1. Shigehara T,
    2. Zaragoza C,
    3. Kitiyakara C,
    4. Takahashi H,
    5. Lu H,
    6. Moeller M,
    7. Holzman LB,
    8. Kopp JB
    : Inducible podocyte-specific gene expression in transgenic mice. J Am Soc Nephrol 14: 1998–2003, 2003pmid:12874453
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Smeets B,
    2. Uhlig S,
    3. Fuss A,
    4. Mooren F,
    5. Wetzels JF,
    6. Floege J,
    7. Moeller MJ
    : Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol 20: 2604–2615, 2009pmid:19917779
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Smeets B,
    2. Kuppe C,
    3. Sicking EM,
    4. Fuss A,
    5. Jirak P,
    6. van Kuppevelt TH,
    7. Endlich K,
    8. Wetzels JF,
    9. Gröne HJ,
    10. Floege J,
    11. Moeller MJ
    : Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 22: 1262–1274, 2011pmid:21719782
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Forbes MS,
    2. Thornhill BA,
    3. Chevalier RL
    : Proximal tubular injury and rapid formation of atubular glomeruli in mice with unilateral ureteral obstruction: A new look at an old model. Am J Physiol Renal Physiol 301: F110–F117, 2011pmid:21429968
    OpenUrlCrossRefPubMed
  31. ↵
    1. Truong LD,
    2. Petrusevska G,
    3. Yang G,
    4. Gurpinar T,
    5. Shappell S,
    6. Lechago J,
    7. Rouse D,
    8. Suki WN
    : Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int 50: 200–207, 1996pmid:8807589
    OpenUrlCrossRefPubMed
  32. ↵
    1. Woolf AS,
    2. Feather SA,
    3. Bingham C
    : Recent insights into kidney diseases associated with glomerular cysts. Pediatr Nephrol 17: 229–235, 2002pmid:11956871
    OpenUrlCrossRefPubMed
  33. ↵
    1. Ojeda JL,
    2. García-Porrero JA,
    3. Hurle JM
    : Experimental formation of podocytes in the parietal layer of the Bowman’s capsule. Experientia 35: 1658–1660, 1979pmid:520491
    OpenUrlCrossRefPubMed
  34. ↵
    1. Bialestock D
    : The morphogenesis of renal cysts in the stillborn studied by micro-dissection technique. J Pathol Bacteriol 71: 51–59, 1956pmid:13307334
    OpenUrlCrossRefPubMed
    1. Vlachos J,
    2. Tsakraklidis V
    : Glomerular cysts. An unusual variety of “polycystic kidneys”: Report of two cases. Am J Dis Child 114: 379–384, 1967pmid:6047237
    OpenUrlCrossRefPubMed
  35. ↵
    1. Oh Y,
    2. Onoyama K,
    3. Kobayashi K,
    4. Nanishi F,
    5. Mitsuoka W,
    6. Ohchi N,
    7. Tsuruda H,
    8. Fujishima M
    : Glomerulocystic kidneys. Report of an adult case. Nephron 43: 299–302, 1986pmid:3736741
    OpenUrlCrossRefPubMed
  36. ↵
    1. Nagata M,
    2. Yamaguchi Y,
    3. Komatsu Y,
    4. Ito K
    : Mitosis and the presence of binucleate cells among glomerular podocytes in diseased human kidneys. Nephron 70: 68–71, 1995pmid:7617119
    OpenUrlCrossRefPubMed
  37. ↵
    1. Pabst R,
    2. Sterzel RB
    : Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int 24: 626–631, 1983pmid:6663985
    OpenUrlCrossRefPubMed
  38. ↵
    1. Wharram BL,
    2. Goyal M,
    3. Wiggins JE,
    4. Sanden SK,
    5. Hussain S,
    6. Filipiak WE,
    7. Saunders TL,
    8. Dysko RC,
    9. Kohno K,
    10. Holzman LB,
    11. Wiggins RC
    : Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941–2952, 2005pmid:16107576
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. Wiggins RC
    : The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int 71: 1205–1214, 2007pmid:17410103
    OpenUrlCrossRefPubMed
  40. ↵
    1. Sagrinati C,
    2. Netti GS,
    3. Mazzinghi B,
    4. Lazzeri E,
    5. Liotta F,
    6. Frosali F,
    7. Ronconi E,
    8. Meini C,
    9. Gacci M,
    10. Squecco R,
    11. Carini M,
    12. Gesualdo L,
    13. Francini F,
    14. Maggi E,
    15. Annunziato F,
    16. Lasagni L,
    17. Serio M,
    18. Romagnani S,
    19. Romagnani P
    : Isolation and characterization of multipotent progenitor cells from the Bowman’s capsule of adult human kidneys. J Am Soc Nephrol 17: 2443–2456, 2006pmid:16885410
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. Moeller MJ,
    2. Soofi A,
    3. Hartmann I,
    4. Le Hir M,
    5. Wiggins R,
    6. Kriz W,
    7. Holzman LB
    : Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 15: 61–67, 2004pmid:14694158
    OpenUrlAbstract/FREE Full Text
    1. Ding M,
    2. Cui S,
    3. Li C,
    4. Jothy S,
    5. Haase V,
    6. Steer BM,
    7. Marsden PA,
    8. Pippin J,
    9. Shankland S,
    10. Rastaldi MP,
    11. Cohen CD,
    12. Kretzler M,
    13. Quaggin SE
    : Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat Med 12: 1081–1087, 2006pmid:16906157
    OpenUrlCrossRefPubMed
  42. ↵
    1. Thorner PS,
    2. Ho M,
    3. Eremina V,
    4. Sado Y,
    5. Quaggin S
    : Podocytes contribute to the formation of glomerular crescents. J Am Soc Nephrol 19: 495–502, 2008pmid:18199804
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Ichimura K,
    2. Kurihara H,
    3. Sakai T
    : Primary cilia disappear in rat podocytes during glomerular development. Cell Tissue Res 341: 197–209, 2010pmid:20495826
    OpenUrlCrossRefPubMed
  44. ↵
    1. Praetorius HA,
    2. Leipziger J
    : Primary cilium-dependent sensing of urinary flow and paracrine purinergic signaling. Semin Cell Dev Biol 24: 3–10, 2013pmid:23085624
    OpenUrlCrossRefPubMed
    1. Kotsis F,
    2. Boehlke C,
    3. Kuehn EW
    : The ciliary flow sensor and polycystic kidney disease. Nephrol Dial Transplant 28: 518–526, 2013pmid:23314319
    OpenUrlCrossRefPubMed
  45. ↵
    1. Ohse T,
    2. Pippin JW,
    3. Chang AM,
    4. Krofft RD,
    5. Miner JH,
    6. Vaughan MR,
    7. Shankland SJ
    : The enigmatic parietal epithelial cell is finally getting noticed: A review. Kidney Int 76: 1225–1238, 2009pmid:19847153
    OpenUrlCrossRefPubMed
  46. ↵
    1. Soriano P
    : Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21: 70–71, 1999pmid:9916792
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 25 (1)
Journal of the American Society of Nephrology
Vol. 25, Issue 1
January 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Origin of Parietal Podocytes in Atubular Glomeruli Mapped by Lineage Tracing
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Origin of Parietal Podocytes in Atubular Glomeruli Mapped by Lineage Tracing
Kevin Schulte, Katja Berger, Peter Boor, Peggy Jirak, Irwin H. Gelman, Kenton P. Arkill, Christopher R. Neal, Wilhelm Kriz, Jürgen Floege, Bart Smeets, Marcus J. Moeller
JASN Jan 2014, 25 (1) 129-141; DOI: 10.1681/ASN.2013040376

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Origin of Parietal Podocytes in Atubular Glomeruli Mapped by Lineage Tracing
Kevin Schulte, Katja Berger, Peter Boor, Peggy Jirak, Irwin H. Gelman, Kenton P. Arkill, Christopher R. Neal, Wilhelm Kriz, Jürgen Floege, Bart Smeets, Marcus J. Moeller
JASN Jan 2014, 25 (1) 129-141; DOI: 10.1681/ASN.2013040376
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Concise Methods
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Single-Cell Chromatin and Gene-Regulatory Dynamics of Mouse Nephron Progenitors
  • Myeloid CCR2 Promotes Atherosclerosis after AKI
  • Intestinal Bacterial Translocation Contributes to Diabetic Kidney Disease
Show more Basic Research

Cited By...

  • Unraveling the Complexity of the Renal Mononuclear Phagocyte System by Genetic Cell Lineage Tracing
  • FSGS as an Adaptive Response to Growth-Induced Podocyte Stress
  • Google Scholar

Similar Articles

Related Articles

  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals
  • Wolters Kluwer Partnership

© 2022 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire